A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy
Clinical trial NCT05917509 · COMPLETED
Trial details
- NCT number
- NCT05917509
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2025-09-16
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.